Recurrent mixed tumors of the parotid gland—results of surgical therapy
Recurrent mixed tumors of the parotid gland—results of surgical therapy
复制标题
腮腺复发性混合瘤——手术治疗的结果
DOI：
10.1288/00005537-197802000-00008
复制
发表时间：
1978
期刊：
影响因子：
--
通讯作者：
T. Calcaterra
中科院分区：
文献类型：
--
作者：
W. Fee;D. Goffinet;T. Calcaterra
本文回顾了1955年至1973年在斯坦福大学和加州大学洛杉矶医学中心治疗的26例腮腺复发性肿瘤的临床过程和治疗方法。七种方法的管理完全肿瘤切除和避免永久性面神经损伤进行了讨论。通过对26例腮腺混合瘤手术和/或放疗后44例复发病例的分析，我们得出以下结论：首次复发的平均间隔时间为7.7年（范围3-21年），而第二次复发的平均间隔时间仅为2.1年。第三次复发的平均时间为4.3年。旨在保留面神经的手术导致52%的患者出现暂时性面神经麻痹或瘫痪，29%的患者持续存在永久性损伤（至少随访3年）;然而，只有8%的患者出现永久性面神经麻痹，涉及面神经超过20%。
The clinical courses and methods of therapy of 26 patients with recurrent tumors of the parotid gland treated at the Stanford University and University of California at Los Angeles Medical Centers between 1955 and 1973 are reviewed. Seven approaches to the management of complete tumor removal and avoidance of permanent facial nerve injury are discussed. After analysis of 44 recurrences in 26 patients with mixed parotid tumors treated surgically and/or with radiation therapy, we concluded the following: The mean interval to first recurrence was 7.7 years (range 3–21 years), while that of the second was only 2.1 years. The mean time to third recurrence was 4.3 years. Surgery designed to spare the facial nerve resulted in transitory facial paresis or paralysis in 52% of the patients and permanent impairment persisted in 29% (minimum 3 year follow‐up); however, only 8% had a permanent facial paralysis involving greater than 20% of the facial nerve.